Business Report prepared by: Irving Bronfman, CA (Ret)

Company Report

A large number of our shareholders responded to our recent rights offering. We now have 19,238,622 issued shares that are owned by 278 shareholders. Many of our shareholders understand the significance of our technology and the huge benefit that it will have for humanity. We have the ability to eradicate the scourge of mould from our homes and workplaces. It is such a phenomenal concept that people have difficulty to fully understand its implications. The following paragraphs should help to explain the facts about mould, the disastrous effect that it has on human and animal health, the source of the problem, its recent growth in society and our remedy for its extermination. Scientists to whom we have revealed our technology are amazed that we have the solution to the problem of mould sickness. They associate our discovery to be comparable with the detection of penicillin by Alexander Fleming and the finding of insulin by Frederick Banting and Charles Best.

From an investment perspective, the demand for our technology for eliminating mould translates into an extraordinary opportunity for large profits.

Read full report... or download in PDF format

Ten Business Resolution for Year 2010

1. We are launching what many in our investment community are projecting as the most significant public company filing to have taken place in years.
   
   
2. The company has redesigned its business model in order to operate with no investment in equipment or product cost and with only a small staff manage the flow of licence fee revenues.
   
   
3. Revenues are expected to be exceptionally high and with low overhead will result in superior earnings per share and distribution of dividends.
   
   
4. Company policy prohibits the spending money on acquisitions, diversions or growth strategies so that the majority of net earnings will be distributed to the shareholders. There is no better business than that presented by our technological breakthrough.
   
   
5. A section of the company's website will provide for postings of investor's intent to buy and sell shares in order to foster internal trades among the family of Rx100 shareholders.
   
   
6. The company's website will have a listing of qualified, licensed brokers who are knowledgeable and supportive about the company\s activities in order to facilitate active market making and provide liquidity and ease of trading, globally.
   
   
7. The company's website will also feature stock trading and company news in realtime so that shareholders and potential investors will be provided with current information.
   
   
8. This year marks the implementation of Rx100 filler technology which provides a unique and low cost solution to eliminate mould from buildings an historic first.
   
   
9. Most people are unaware that most building materials contain calcium carbonate filler which attracts moisture from the air. The moisture fosters the growth of mould causing allergies and numerous sicknesses. We began a public awareness program in December 2009 which will be intensified through newspapers, radio, TV and social networking and to deliver the message that our company has the solution to eliminate mould.
   
   
10. The 2010 calendar year marks a benchmark for the people of this world to record a new approach to dealing with allergic sicknesses and property damage caused by mould. Rather than resorting to ineffective pharmaceuticals and replacing building materials with similarly tainted products, allergies will disappear due to the introduction of antimicrobial Rx100 filler in homes and workplaces.